Testicular Cancer clinical trials in Missouri

6 actively recruiting testicular cancer trials at 24 sites across Missouri.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it dev…

Sponsor: Children's Oncology Group

NCT ID: NCT03067181

Sites in Missouri:

Parkland Health Center-Bonne Terre — Bonne Terre, Missouri
Mercy Cancer Center - Cape Girardeau — Cape Girardeau, Missouri
Saint Francis Medical Center — Cape Girardeau, Missouri
University of Missouri Children's Hospital — Columbia, Missouri
Parkland Health Center - Farmington — Farmington, Missouri

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab o…

Sponsor: Children's Oncology Group

NCT ID: NCT03959085

Sites in Missouri:

University of Missouri Children's Hospital — Columbia, Missouri
Children's Mercy Hospitals and Clinics — Kansas City, Missouri
Cardinal Glennon Children's Medical Center — St Louis, Missouri
Washington University School of Medicine — St Louis, Missouri
Mercy Hospital Saint Louis — St Louis, Missouri

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT03866382

Sites in Missouri:

Mercy Oncology and Hematology - Clayton-Clarkson — Ballwin, Missouri
Central Care Cancer Center - Bolivar — Bolivar, Missouri
Parkland Health Center-Bonne Terre — Bonne Terre, Missouri
Cox Cancer Center Branson — Branson, Missouri
Mercy Cancer Center - Cape Girardeau — Cape Girardeau, Missouri

View on ClinicalTrials.gov →

NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group

NCT ID: NCT05108298

Sites in Missouri:

Saint Louis Cancer and Breast Institute-Ballwin — Ballwin, Missouri
Central Care Cancer Center - Bolivar — Bolivar, Missouri
Cox Cancer Center Branson — Branson, Missouri
Saint Francis Medical Center — Cape Girardeau, Missouri
Southeast Cancer Center — Cape Girardeau, Missouri

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in Missouri:

Massive Bio SYNERGY-AI site — Kansas City, Missouri
Massive Bio SYNERGY-AI site — St Louis, Missouri

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Missouri:

Saint Luke's Cancer Institute, East — Kansas City, Missouri
Saint Luke's Cancer Institute — Kansas City, Missouri
Saint Luke's Cancer Institute, Kansas City North — Kansas City, Missouri
Saint Luke's Cancer Institute, Liberty — Liberty, Missouri
North Kansas City Hospital — North Kansas City, Missouri

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20